Iraqi security forces destroyed eight extremist strongholds in northern Iraq. On December 12, local time, the Iraqi Joint Operations Command issued a statement saying that Iraqi security forces are continuing to track and crack down on members of the extremist organization "Islamic State" in the country. Recently, in the hamlin Mountains in Kirkuk province, Iraqi security forces destroyed eight extremist strongholds, including personnel hiding places and weapons storage facilities. (CCTV News)Israel used drones to attack the town of Shyam, a major town in southern Lebanon. On the 12th, local time, the reporter of the General Station learned that Israel used drones to launch an attack in the town of Shyam, a major town in southern Lebanon. Preliminary reports show that some people were injured in the incident. (CCTV News)European Central Bank President Lagarde: Labor cost growth will slow down.
Baiyang Pharmaceutical Group signed an agreement with Peking University Hospital. On December 12, Baiyang Pharmaceutical Group signed a cooperation agreement with Peking University No.1 Hospital, and obtained the exclusive right to patent, clinical development and registration, production and marketing of "targeted integrin small molecule inhibitor" in Peking University Hospital.According to statistics, on December 12th, as of press time, five A-share listed companies including Alaide, Zhongzhong Technology, Yiwang Yichuang, Crystal Optoelectronics and Decai Co., Ltd. disclosed their holdings.Adobe(ADBE.O) fell by 12%, the biggest one-day drop since March 15th.
European Central Bank President Lagarde: Potential inflation and inflation continue to return to the target in the same direction.Baiyang Pharmaceutical Group signed an agreement with Peking University Hospital. On December 12, Baiyang Pharmaceutical Group signed a cooperation agreement with Peking University No.1 Hospital, and obtained the exclusive right to patent, clinical development and registration, production and marketing of "targeted integrin small molecule inhibitor" in Peking University Hospital.Novo Nordisk: After the clinical trial results of kidney therapy were released, European regulators gave Ozempic a positive label evaluation.